Neuroprotective Effects of Phenothiazines on Acute Ischemic Stroke
CNS Neuroscience & Therapeutics · 2026-06 · 32 (6)
DOI: 10.1002/cns.70960 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 09.06.2026. Verfasst von Qi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Neuroprotective Agents, Phenothiazines, Ischemic Stroke, Brain Ischemia. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Standard therapeutic strategies for acute ischemic stroke (AIS) include endovascular mechanical thrombectomy, intravenous thrombolysis, bridging therapy, and conventional conservative treatment. Despite the implementation of standardized treatments, nearly half of patients still experience significant motor or speech dysfunction, severely impacting their quality of life. Consequently, there is a pressing need for effective neuroprotective adjunctive therapies to further improve functional outcomes and prognosis. Phenothiazines, primarily chlorpromazine and promethazine (C + P), have been proposed as potential neuroprotective agents. Preclinical evidence suggests that phenothiazines may induce mild hypothermic responses, exert anti‐inflammatory effects, and promote a hypometabolic state, thereby potentially contributing to improved neurological outcomes.
Methods
We reviewed and synthesized the mechanisms underlying the neuroprotective effects of phenothiazines, with a particular focus on C + P.
Results
This review highlights the neuroprotective mechanisms of phenothiazines related to mild hypothermia, anti‐inflammation, and metabolic reduction, along with relevant preclinical and clinical evidence. We also compare the distinct mechanisms of action between C + P and conventional anesthetic sedatives and draw partial comparisons with natural hibernation. Our findings reveal that C + P possesses unique features and advantages in neuroprotection, particularly regarding metabolic suppression and hypothermia.
Conclusions
This review explores the adjunctive role of phenothiazines following AIS and elucidates their modulatory mechanisms, which may exert neuroprotective effects through multiple pathways and potentially improve AIS outcomes. This approach may facilitate the identification of novel specific targets for conventional drugs, thereby offering a new perspective on addressing the challenges associated with AIS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Neurology and China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Neurology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qian Fo Shan Hospital, Jinan, China.
- Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China.
ORCID-Profile: Weili Li, Xunming Ji
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Q., Li, W., Wu, D., Xu, S., & Ji, X. (2026). Neuroprotective Effects of Phenothiazines on Acute Ischemic Stroke. CNS Neuroscience & Therapeutics, 32(6). https://doi.org/10.1002/cns.70960
Vancouver
Wang Q, Li W, Wu D, Xu S, Ji X. Neuroprotective Effects of Phenothiazines on Acute Ischemic Stroke. CNS Neuroscience & Therapeutics. 2026;32(6). doi:10.1002/cns.70960
BibTeX
@article{Wang2026,
author = {Wang, Qi and Li, Weili and Wu, Di and Xu, Shuaili and Ji, Xunming},
title = {Neuroprotective Effects of Phenothiazines on Acute Ischemic Stroke},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {6},
doi = {10.1002/cns.70960}
}
EUVIMED